The 2022 MedTech Contract Manufacturing Report

Alira Health in collaboration with MassMEDIC

Publications
Category:
Published on:
March 28, 2022
Written by:
Carlo Stimamiglio, Campbell Roellig, Alice Scala, Brian Johnson

2021 was a remarkable year for the global medical device industry. Just as healthcare systems were learning to cope with the enduring effects of the pandemic, ramping up procedures, and product demand, device manufacturers were hit by the most severe supply chain crisis in decades. 

  • The MedTech industry expanded by +16.8%, driven by the catch-up of elective procedures and the prolonged demand for COVID-related diagnostics and consumables, mitigating the potentially disruptive impact of such a crunch in the supply-demand dynamic. 
  • Outsourced manufacturers also benefitted from the general market recovery since the flat 2020 performance. The US CDMO market, the focus of this report, lagged with a +12.9% aggregate performance, its growth potential constrained by these macro-challenges. 
  • During the last two volatile years, the OEMs’ long-term pursuit of supply chain efficiencies slowed down, in favor of efforts aimed at increasing global capacity, inventories and securing the continuity of product supplies. 
  • Despite the widespread growth across most segments of MedTech and the positive medium-term outlook for outsourcing organizations, many factors threaten the sustainability of the medical device manufacturing industry. 

Our analysis investigates these continuing trends and their meaning for medical device CDMOs and their capital sponsors. 

Fill in the form below to download the ” The 2022 MedTech Contract Manufacturing Report”. Have questions? Reach out to us at [email protected] 

Related news

News February 7, 2023
The 2023 MedTech Contract Manufacturing Report is released in the U.S.
Alira Health, a global healthcare advisory, clinical research and technology company, announced today the release of the 2023 U.S. MedTech Contract Manufacturing Report in collaboration(...)
MedTech
Publications February 7, 2023
The 2023 U.S. Medtech Contract Manufacturing Report
Read this report to discover the trends in the world of medical device CDMOs and their meaning for the industry.
MedTech
Publications February 2, 2023
Outlook 2023: Firms Prepare For ‘World Where Health Care Has No Limits’
In the latest publication by Medtech Insights by Pharma Intelligence, executives at top device companies and other stakeholders share their expectations.
MedTech Pharma
News January 31, 2023
The Playbook for Patient Engagement in MedTech in the U.S. is Launched
The MedTech Patient Engagement Think Tank announced today the launch of the Playbook for Patient Engagement in MedTech in the U.S.
MedTech Patient Engagement
Publications January 31, 2023
A Playbook for Patient Engagement in MedTech in the U.S.
“A Playbook for Patient Engagement in MedTech in the U.S.” is a result of amalgamating ideas, research, findings, and forecasts from industry subject matter experts that together(...)
MedTech Patient Engagement
Publications January 19, 2023
Medical Device Regulation in 2023: A Window of Opportunity
We spoke with our team of regulatory experts about the recent news regarding the MDR and the opportunity it presents to device manufacturers in 2023.
Medical Devices MedTech Regulatory
Publications January 19, 2023
What’s Next for Diabetes: Patient Engagement, Personalization, and Usable Technology
Alira Health partnered with the ADA to support this conversation and explore the most important topics emerging from patients, physicians, specialists, and patient advocates including(...)
Clinical Trials Diabetes MedTech Patient Engagement
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.